Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Add-on Qvar versus Flixotide on airway inflammation markers in refractory asthma
2008-001811-40Phase 4Completed
- Sponsor
- University of Dundee
- Start
- Jun 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of beclomethasone, fluticasone propionate and salmeterol + fluticasone in asthma (2 arms), sponsored by University of Dundee. Primary endpoint: Suppression of alveolar nitric oxide. Started Jun 2008; status: completed.
02
Drugs
beclomethasonefluticasone propionatesalmeterol + fluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on 2008-001811-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001811-40.